Differential diagnostic performance of a panel of plasma biomarkers for different types of dementia

INTRODUCTION: We explored what combination of blood‐based biomarkers (amyloid beta [Aβ](1‐42/1‐40), phosphorylated tau [p‐tau]181, neurofilament light [NfL], glial fibrillary acidic protein [GFAP]) differentiates Alzheimer's disease (AD) dementia, frontotemporal dementia (FTD), and dementia wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Thijssen, Elisabeth H., Verberk, Inge M.W., Kindermans, Jana, Abramian, Adlin, Vanbrabant, Jeroen, Ball, Andrew J., Pijnenburg, Yolande, Lemstra, Afina W., van der Flier, Wiesje M., Stoops, Erik, Hirtz, Christophe, Teunissen, Charlotte E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Blood‐based Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107685/
https://www.ncbi.nlm.nih.gov/pubmed/35603139
http://dx.doi.org/10.1002/dad2.12285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107685/
https://www.ncbi.nlm.nih.gov/pubmed/35603139
http://dx.doi.org/10.1002/dad2.12285

Ejemplares similares